Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
therapeutic vaccine
Biotech
GSK axes hepatitis B vaccine trial after missing efficacy goal
GSK ended the phase 1/2 trial after the therapeutic vaccine regimen missed the efficacy endpoint, denting its hopes of creating a functional cure.
Nick Paul Taylor
Dec 4, 2024 5:15am
Sanofi snaps up Origimm for acne vaccine, plans mRNA prospect
Dec 1, 2021 2:14am
Aelix posts HIV vaccine data ahead of Gilead combo readout
Mar 11, 2021 8:55am
Gilead Sciences pens early-stage HIV vaccine pact with Gritstone
Feb 1, 2021 7:15am
Korean VCs pile into PDC*line to bankroll NSCLC vaccine trial
Jan 22, 2020 7:33am
